John Fung to Survival Rate
This is a "connection" page, showing publications John Fung has written about Survival Rate.
Connection Strength
1.238
-
Duct-to-duct biliary reconstruction in patients with primary sclerosing cholangitis undergoing liver transplantation. HPB (Oxford). 2011 Sep; 13(9):651-5.
Score: 0.075
-
Long-term outcome of adding mycophenolate mofetil to tacrolimus for nephrotoxicity following liver transplantation. Transplantation. 2005 Sep 27; 80(6):859-64.
Score: 0.050
-
Tobacco use following liver transplantation for alcoholic liver disease: an underestimated problem. Liver Transpl. 2005 Jun; 11(6):679-83.
Score: 0.049
-
[Analysis of causes of late mortality in liver transplant recipients]. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2004 Sep; 16(9):547-51.
Score: 0.046
-
Pregnancy after liver transplantation with tacrolimus immunosuppression: a single center's experience update at 13 years. Transplantation. 2003 Sep 15; 76(5):827-32.
Score: 0.043
-
Orthotopic liver transplantation in patients with human immunodeficiency virus and end-stage liver disease. Liver Transpl. 2003 Mar; 9(3):239-47.
Score: 0.042
-
Posttransplant lymphoproliferative disorders in liver transplantation: a 20-year experience. Ann Surg. 2002 Oct; 236(4):429-36; discussion 436-7.
Score: 0.041
-
Interaction between tacrolimus and antiretroviral agents in human immunodeficiency virus-positive liver and kidney transplantation patients. Transplant Proc. 2002 Aug; 34(5):1540-1.
Score: 0.040
-
Fungal infection in liver transplantation. Transpl Infect Dis. 2002; 4 Suppl 3:18-23.
Score: 0.039
-
Prospective randomized trial of tacrolimus and prednisone versus tacrolimus, prednisone, and mycophenolate mofetil: complete report on 350 primary adult liver transplantations. Transplant Proc. 2001 Feb-Mar; 33(1-2):1342-4.
Score: 0.036
-
Causes of death after liver transplantation in 4000 consecutive patients: 2 to 19 year follow-up. Transplant Proc. 2001 Feb-Mar; 33(1-2):1482-3.
Score: 0.036
-
Kidney transplantation for end-stage renal failure in liver transplant recipients with hepatitis C viral infection. Transplantation. 2001 Jan 27; 71(2):267-71.
Score: 0.036
-
Use of non-heart-beating donors. Transplant Proc. 2000 Nov; 32(7):1510-1.
Score: 0.036
-
A prospective randomized trial of tacrolimus and prednisone versus tacrolimus, prednisone, and mycophenolate mofetil in primary adult liver transplant recipients: an interim report. Transplantation. 1998 Nov 27; 66(10):1395-8.
Score: 0.031
-
Clinical outcome of patients infected with hepatitis C virus infection on survival after primary liver transplantation under tacrolimus. Liver Transpl Surg. 1998 Nov; 4(6):448-54.
Score: 0.031
-
Liver transplantation under tacrolimus in infants, children, adults, and seniors: long-term results, survival, and adverse events in 1000 consecutive patients. Transplant Proc. 1998 Jun; 30(4):1403-4.
Score: 0.030
-
Infectivity of hepatic allografts with antibodies to hepatitis B virus. Transplantation. 1997 Dec 15; 64(11):1582-4.
Score: 0.029
-
Donor IFNL4 Genotype Is Associated with Early Post-Transplant Fibrosis in Recipients with Hepatitis C. PLoS One. 2016; 11(11):e0166998.
Score: 0.027
-
Between Scylla and Charybdis. Ann Surg. 1995 Aug; 222(2):107-8.
Score: 0.025
-
De novo sirolimus and reduced-dose tacrolimus versus standard-dose tacrolimus after liver transplantation: the 2000-2003 phase II prospective randomized trial. Am J Transplant. 2014 Feb; 14(2):356-66.
Score: 0.022
-
Multicentre results of stereotactic body radiotherapy for secondary liver tumours. HPB (Oxford). 2013 Nov; 15(11):851-7.
Score: 0.021
-
Combined heart and liver transplantation: the Cleveland Clinic experience. Ann Thorac Surg. 2013 Jan; 95(1):179-82.
Score: 0.020
-
Intestinal transplantation in composite visceral grafts or alone. Ann Surg. 1992 Sep; 216(3):223-33; discussion 233-4.
Score: 0.020
-
Surgical complications in 275 HIV-infected liver and/or kidney transplantation recipients. Surgery. 2012 Sep; 152(3):376-81.
Score: 0.020
-
Multicenter results of stereotactic body radiotherapy (SBRT) for non-resectable primary liver tumors. Acta Oncol. 2012 May; 51(5):575-83.
Score: 0.019
-
The role of the A2a receptor agonist, regadenoson, in modulating hepatic artery flow in the porcine small-for-size liver graft. J Surg Res. 2012 May 01; 174(1):e37-45.
Score: 0.019
-
Association between donor-recipient serum sodium differences and orthotopic liver transplant graft function. Liver Transpl. 2008 Jan; 14(1):59-65.
Score: 0.015
-
Immunosuppression for liver transplantation in HCV-infected patients: mechanism-based principles. Liver Transpl. 2005 Nov; 11(11):1343-52.
Score: 0.013
-
Synergistic effect of cold and warm ischemia time on postoperative graft outcome in human liver transplantation. Hepatogastroenterology. 2004 Sep-Oct; 51(59):1413-6.
Score: 0.012
-
Pediatric liver transplantation in 808 consecutive children: 20-years experience from a single center. Transplant Proc. 2002 Aug; 34(5):1955-7.
Score: 0.010
-
Pediatric liver transplantation. A single center experience spanning 20 years. Transplantation. 2002 Mar 27; 73(6):941-7.
Score: 0.010
-
Ethical considerations and rationale of adult-to-adult living donor liver transplantation. Liver Transpl. 2001 Oct; 7(10):921-7.
Score: 0.009
-
Outcome after steroid withdrawal in adult renal transplant patients receiving tacrolimus-based immunosuppression. Transplant Proc. 2001 Feb-Mar; 33(1-2):1235-6.
Score: 0.009
-
Outcome after steroid withdrawal in pediatric renal transplant patients receiving tacrolimus-based immunosuppression. Transplantation. 2000 Sep 15; 70(5):760-4.
Score: 0.009
-
The impact of positive T-cell lymphocytotoxic crossmatch on intestinal allograft rejection and survival. Transplant Proc. 2000 Sep; 32(6):1197-8.
Score: 0.009
-
Posttransplant lymphoproliferative disorders in small bowel allograft recipients. Transplant Proc. 2000 Sep; 32(6):1213.
Score: 0.009
-
The long-term efficacy of multivisceral transplantation. Transplant Proc. 2000 Sep; 32(6):1219-20.
Score: 0.009
-
Results of pancreas transplantation after steroid withdrawal under tacrolimus immunosuppression. Transplantation. 2000 Jan 27; 69(2):265-71.
Score: 0.008
-
Simultaneous administration of adjuvant donor bone marrow in pancreas transplant recipients. Ann Surg. 1999 Sep; 230(3):372-9; discussion 379-81.
Score: 0.008
-
Clinical intestinal transplantation in 1998: Pittsburgh experience. Acta Gastroenterol Belg. 1999 Apr-Jun; 62(2):244-7.
Score: 0.008
-
A prospective, randomized trial of tacrolimus/prednisone versus tacrolimus/prednisone/mycophenolate mofetil in renal transplant recipients. Transplantation. 1999 Feb 15; 67(3):411-5.
Score: 0.008
-
A prospective, randomized trial of tacrolimus/prednisone vs tacrolimus/prednisone/mycophenolate mofetil in renal transplantation: 1-year actuarial follow-up. Transplant Proc. 1999 Feb-Mar; 31(1-2):1134.
Score: 0.008
-
Long-term results of pancreas transplantation under tacrolius immunosuppression. Transplantation. 1999 Jan 27; 67(2):266-72.
Score: 0.008
-
Simultaneous pancreas-kidney transplantation at the University of Pittsburgh. Clin Transpl. 1999; 217-21.
Score: 0.008
-
A prospective, randomized trial to compare tacrolimus and prednisone with and without mycophenolate mofetil in patients undergoing renal transplantation: first report. J Urol. 1998 Dec; 160(6 Pt 1):1982-5; discussion 1985-6.
Score: 0.008
-
Tacrolimus enhances the immunosuppressive effect of cyclophosphamide but not that of leflunomide or mycophenolate mofetil in a model of discordant liver xenotransplantation. Transplant Proc. 1998 Jun; 30(4):1091-2.
Score: 0.008
-
Adjuvant bone marrow infusion in clinical organ transplant recipients. Transplant Proc. 1998 Jun; 30(4):1367-8.
Score: 0.008
-
Outcome after steroid withdrawal in renal transplant patients receiving tacrolimus-based immunosuppression. Transplant Proc. 1998 Jun; 30(4):1375-7.
Score: 0.008
-
Clinical intestinal transplantation: new perspectives and immunologic considerations. J Am Coll Surg. 1998 May; 186(5):512-25; discussion 525-7.
Score: 0.007
-
Current status of intestinal transplantation in children. J Pediatr Surg. 1998 Feb; 33(2):243-54.
Score: 0.007
-
The influence of hepatitis C virus genotypes on the outcome of liver transplantation. Liver Transpl Surg. 1998 Jan; 4(1):22-7.
Score: 0.007
-
Outcome of kidney transplantation in African-Americans using tacrolimus. Transplant Proc. 1997 Dec; 29(8):3731-2.
Score: 0.007
-
Cardiac operations in solid-organ transplant recipients. Ann Thorac Surg. 1997 Nov; 64(5):1270-8.
Score: 0.007
-
Treatment of fibrolamellar hepatoma with subtotal hepatectomy or transplantation. Hepatology. 1997 Oct; 26(4):877-83.
Score: 0.007
-
Hepatitis C virus genotypes in liver transplant recipients: impact on posttransplant recurrence, infections, response to interferon-alpha therapy and outcome. Transplantation. 1997 Aug 15; 64(3):422-6.
Score: 0.007
-
Survival and quality of life after liver transplantation for acute alcoholic hepatitis. Liver Transpl Surg. 1997 May; 3(3):240-4.
Score: 0.007
-
Long-term follow-up of tacrolimus rescue therapy for renal allograft rejection. Transplant Proc. 1997 Feb-Mar; 29(1-2):310.
Score: 0.007
-
Treatment of isolated pancreatic islets to reverse pancreatectomy-induced and insulin-dependent type I diabetes in humans: a 6-year experience. Transplant Proc. 1997 Feb-Mar; 29(1-2):746-7.
Score: 0.007
-
Tacrolimus rescue therapy for renal allograft rejection--five-year experience. Transplantation. 1997 Jan 27; 63(2):223-8.
Score: 0.007
-
Long-term results after liver transplantation for primary hepatic epithelioid hemangioendothelioma. Ann Surg Oncol. 1995 Nov; 2(6):483-7.
Score: 0.006
-
Reduction of primary nonfunction with prostaglandin E1 after clinical liver transplantation. Transplant Proc. 1995 Apr; 27(2):1862-7.
Score: 0.006
-
One thousand consecutive primary orthotopic liver transplants under FK 506: survival and adverse events. Transplant Proc. 1995 Feb; 27(1):1099-104.
Score: 0.006
-
A prospective, randomized trial of FK 506/prednisone vs FK 506/azathioprine/prednisone in renal transplant patients. Transplant Proc. 1995 Feb; 27(1):814-7.
Score: 0.006
-
Outcome of liver transplantation using donors 60 to 79 years of age. Transplant Proc. 1995 Feb; 27(1):1184-5.
Score: 0.006
-
Liver and kidney transplantation from non-heart beating donors: the Pittsburgh experience. Transplant Proc. 1995 Feb; 27(1):710-2.
Score: 0.006
-
Assessment of five-year experience with abdominal organ cluster transplantation. J Am Coll Surg. 1995 Jan; 180(1):1-9.
Score: 0.006
-
Single-center experience with primary orthotopic liver transplantation with FK 506 immunosuppression. Ann Surg. 1994 Sep; 220(3):297-308; discussion 308-9.
Score: 0.006
-
Disease gravity and urgency of need as guidelines for liver allocation. Hepatology. 1994 Jul; 20(1 Pt 2):56S-62S.
Score: 0.006
-
Human islet isolation and allotransplantation in 22 consecutive cases. Transplantation. 1992 Feb; 53(2):407-14.
Score: 0.005
-
The spectrum of portal vein thrombosis in liver transplantation. Ann Surg. 1991 Mar; 213(3):199-206.
Score: 0.005
-
The liver transplant waiting list--a single-center analysis. Transplantation. 1991 Jan; 51(1):128-34.
Score: 0.004
-
Liver transplantation in patients over sixty years of age. Transplantation. 1991 Jan; 51(1):271-3.
Score: 0.004
-
Rejection of multivisceral allografts in rats: a sequential analysis with comparison to isolated orthotopic small-bowel and liver grafts. Surgery. 1990 Nov; 108(5):880-9.
Score: 0.004